InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Malabre Richard C. Insider active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 2 reports have been recorded. History available since 31 January 2024. The latest transaction was disclosed on 31 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations